Knockdown of spinal cord postsynaptic density protein-95 prevents the development of morphine tolerance in rats

W. J. Liaw, B. Zhang, F. Tao, M. Yaster, R. A. Johns, Y. X. Tao

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The activation of spinal cord N-methyl-D-aspartate (NMDA) receptors and subsequent intracellular cascades play a pivotal role in the development of opioid tolerance. Postsynaptic density protein-95 (PSD-95), a molecular scaffolding protein, assembles a specific set of signaling proteins around NMDA receptors at neuronal synapses. The current study investigated the possible involvement of PSD-95 in the development of opioid tolerance. Opioid tolerance was induced by intrathecal injection of morphine sulfate (20 μg/10 μl) twice a day for 4 consecutive days. Co-administration of morphine twice daily and PSD-95 antisense oligodeoxynucleotide (50 μg/10 μl) once daily for 4 days not only markedly reduced the PSD-95 expression and its binding to NMDA receptors in spinal cord but also significantly prevented the development of morphine tolerance. In contrast, co-administration of morphine twice daily and PSD-95 missense oligodeoxynucleotide (50 μg/10 μl) once daily for 4 days did not produce these effects. The PSD-95 antisense oligodeoxynucleotide at the doses we used did not affect baseline response to noxious thermal stimulation or locomotor function. The present study indicates that the deficiency of spinal cord PSD-95 attenuates the development of opioid tolerance. These results suggest that PSD-95 might be involved in the central mechanisms of opioid tolerance and provide a possible new target for prevention of development of opioid tolerance.

Original languageEnglish (US)
Pages (from-to)11-15
Number of pages5
JournalNeuroscience
Volume123
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

Morphine
Spinal Cord
Opioid Analgesics
Oligodeoxyribonucleotides
N-Methyl-D-Aspartate Receptors
Spinal Injections
postsynaptic density proteins
Synapses
Proteins
Hot Temperature

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Keywords

  • Antisense technology
  • Hyperalgesia
  • Intrathecal injection
  • NMDA receptors
  • Opioid tolerance

Cite this

Liaw, W. J. ; Zhang, B. ; Tao, F. ; Yaster, M. ; Johns, R. A. ; Tao, Y. X. / Knockdown of spinal cord postsynaptic density protein-95 prevents the development of morphine tolerance in rats. In: Neuroscience. 2004 ; Vol. 123, No. 1. pp. 11-15.
@article{2a4038ba39984c98aa2036918c680b56,
title = "Knockdown of spinal cord postsynaptic density protein-95 prevents the development of morphine tolerance in rats",
abstract = "The activation of spinal cord N-methyl-D-aspartate (NMDA) receptors and subsequent intracellular cascades play a pivotal role in the development of opioid tolerance. Postsynaptic density protein-95 (PSD-95), a molecular scaffolding protein, assembles a specific set of signaling proteins around NMDA receptors at neuronal synapses. The current study investigated the possible involvement of PSD-95 in the development of opioid tolerance. Opioid tolerance was induced by intrathecal injection of morphine sulfate (20 μg/10 μl) twice a day for 4 consecutive days. Co-administration of morphine twice daily and PSD-95 antisense oligodeoxynucleotide (50 μg/10 μl) once daily for 4 days not only markedly reduced the PSD-95 expression and its binding to NMDA receptors in spinal cord but also significantly prevented the development of morphine tolerance. In contrast, co-administration of morphine twice daily and PSD-95 missense oligodeoxynucleotide (50 μg/10 μl) once daily for 4 days did not produce these effects. The PSD-95 antisense oligodeoxynucleotide at the doses we used did not affect baseline response to noxious thermal stimulation or locomotor function. The present study indicates that the deficiency of spinal cord PSD-95 attenuates the development of opioid tolerance. These results suggest that PSD-95 might be involved in the central mechanisms of opioid tolerance and provide a possible new target for prevention of development of opioid tolerance.",
keywords = "Antisense technology, Hyperalgesia, Intrathecal injection, NMDA receptors, Opioid tolerance",
author = "Liaw, {W. J.} and B. Zhang and F. Tao and M. Yaster and Johns, {R. A.} and Tao, {Y. X.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/j.neuroscience.2003.09.007",
language = "English (US)",
volume = "123",
pages = "11--15",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "1",

}

Knockdown of spinal cord postsynaptic density protein-95 prevents the development of morphine tolerance in rats. / Liaw, W. J.; Zhang, B.; Tao, F.; Yaster, M.; Johns, R. A.; Tao, Y. X.

In: Neuroscience, Vol. 123, No. 1, 01.01.2004, p. 11-15.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Knockdown of spinal cord postsynaptic density protein-95 prevents the development of morphine tolerance in rats

AU - Liaw, W. J.

AU - Zhang, B.

AU - Tao, F.

AU - Yaster, M.

AU - Johns, R. A.

AU - Tao, Y. X.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - The activation of spinal cord N-methyl-D-aspartate (NMDA) receptors and subsequent intracellular cascades play a pivotal role in the development of opioid tolerance. Postsynaptic density protein-95 (PSD-95), a molecular scaffolding protein, assembles a specific set of signaling proteins around NMDA receptors at neuronal synapses. The current study investigated the possible involvement of PSD-95 in the development of opioid tolerance. Opioid tolerance was induced by intrathecal injection of morphine sulfate (20 μg/10 μl) twice a day for 4 consecutive days. Co-administration of morphine twice daily and PSD-95 antisense oligodeoxynucleotide (50 μg/10 μl) once daily for 4 days not only markedly reduced the PSD-95 expression and its binding to NMDA receptors in spinal cord but also significantly prevented the development of morphine tolerance. In contrast, co-administration of morphine twice daily and PSD-95 missense oligodeoxynucleotide (50 μg/10 μl) once daily for 4 days did not produce these effects. The PSD-95 antisense oligodeoxynucleotide at the doses we used did not affect baseline response to noxious thermal stimulation or locomotor function. The present study indicates that the deficiency of spinal cord PSD-95 attenuates the development of opioid tolerance. These results suggest that PSD-95 might be involved in the central mechanisms of opioid tolerance and provide a possible new target for prevention of development of opioid tolerance.

AB - The activation of spinal cord N-methyl-D-aspartate (NMDA) receptors and subsequent intracellular cascades play a pivotal role in the development of opioid tolerance. Postsynaptic density protein-95 (PSD-95), a molecular scaffolding protein, assembles a specific set of signaling proteins around NMDA receptors at neuronal synapses. The current study investigated the possible involvement of PSD-95 in the development of opioid tolerance. Opioid tolerance was induced by intrathecal injection of morphine sulfate (20 μg/10 μl) twice a day for 4 consecutive days. Co-administration of morphine twice daily and PSD-95 antisense oligodeoxynucleotide (50 μg/10 μl) once daily for 4 days not only markedly reduced the PSD-95 expression and its binding to NMDA receptors in spinal cord but also significantly prevented the development of morphine tolerance. In contrast, co-administration of morphine twice daily and PSD-95 missense oligodeoxynucleotide (50 μg/10 μl) once daily for 4 days did not produce these effects. The PSD-95 antisense oligodeoxynucleotide at the doses we used did not affect baseline response to noxious thermal stimulation or locomotor function. The present study indicates that the deficiency of spinal cord PSD-95 attenuates the development of opioid tolerance. These results suggest that PSD-95 might be involved in the central mechanisms of opioid tolerance and provide a possible new target for prevention of development of opioid tolerance.

KW - Antisense technology

KW - Hyperalgesia

KW - Intrathecal injection

KW - NMDA receptors

KW - Opioid tolerance

UR - http://www.scopus.com/inward/record.url?scp=0344255683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344255683&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2003.09.007

DO - 10.1016/j.neuroscience.2003.09.007

M3 - Article

C2 - 14667437

AN - SCOPUS:0344255683

VL - 123

SP - 11

EP - 15

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 1

ER -